Skip to main content
Caplight Logo









AlgometRx, Inc.

AlgometRx, Inc.

Private
Washington D.C.Healthcare & Life Scienceshttps://www.algometrx.com/

Last Round

Grant

Nov 1, 2024

Total Funding Raised

$11.24M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AlgometRx, Inc. is a medical device company that develops a non-invasive, handheld diagnostic platform designed to objectively measure pain type and intensity through pupillary response analysis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Application

Keywords

pain assessmentmedical devicepupillometryclinical decision supportdigital healthpain managementnon-invasive monitoringbiometric sensoranalgesic prescribingclinical trial toolsobjective pain measurementmedtechpain techhealthtechremote patient monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlgometRx, Inc. Comparables

Compare AlgometRx, Inc. with similar companies based on industry and business-model similarity.

AlgometRx, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioTraceIT
85%
IDMED
82%
PainQx
81%

AlgometRx, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2024
GrantSep 1, 2022
Early FundingMay 18, 2021
GrantSep 10, 2019

Key People

Founding team and executive leadership

Kevin Jackson

Chief Operating Officer

Executive Team

AlgometRx, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 32% MoM, reaching 2.3K.

  • Mar 3, 2026

    Monthly visitors increased 93% MoM.

AlgometRx, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AlgometRx, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlgometRx, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWashington D.C.
Employee Range1
Year Founded2015
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?